American Medical Systems (AMS), a leading provider of world-class devices and therapies for male and female pelvic health has announced the Canadian launch of AdVance XP, a minimally invasive implant for the treatment of male stress urinary incontinence (SUI). Male SUI is a common side effect of prostate cancer and benign prostatic hyperplasia treatments, such as radical prostatectomy and transurethral resection of the prostate. Built on the success of the AdVance platform, AdVance XP incorporates additional features that are designed to deliver Xtra Performance for improved ease-of-use and clinical outcomes. Enhancements include a redesigned sling that incorporates a new mesh designed to improve procedural reproducibility, longer arms that are easier to use in larger patients, and distinct tissue anchors designed to increase holding power during the critical healing period, following implantation. This latest Health Canada licensing and launch brings AdVance XP to North America for the first time and increases the total number of countries to twelve where this latest AMS innovation is being supplied to physicians and their patients.
